Tandem Diabetes Care | Umsatzkosten

Aktienkurs
19.17
Täglich Wechseln
0.23 1.21%
Monatlich
-15.59%
Jährlich
-46.90%
Q1 Prognose
18.58




Umsatzkosten Veränderung Datum
Abbott USD 4.92B 535M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
AtriCure USD 32.94M 1.72M 2025-09
Baxter International USD 1.88B 66M 2025-09
Becton, Dickinson and Co. USD 5.19B 2.32B 2025-09
Boston Scientific USD 1.84B 82M 2025-12
Cooper Companies USD 464.2M 45.9M 2025-09
Dexcom USD 477.9M 9.6M 2025-09
Edwards Lifesciences USD 345.2M 800K 2025-09
Eli Lilly USD 3.37B 363.7M 2025-12
Globus Medical USD 282.38M 3.42M 2025-09
ICU Medical USD 336.11M 4.69M 2025-09
Insulet USD 196.2M 700K 2025-09
Integra LifeSciences USD 195.07M 11.2M 2025-09
Intuitive Surgical USD 961.9M 119.2M 2025-12
J&J USD 7.97B 689M 2025-12
Masimo USD 140.9M 3.3M 2025-09
Medtronic USD 3.52B 80M 2025-09
Merit Medical Systems USD 197.75M 229K 2025-09
Roche Holding CHF 8.48B 4.61B 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 114.96M 138K 2025-09
Teleflex USD 461.38M 111.57M 2025-09
Zimmer Biomet Holdings USD 735.8M 17M 2025-09


Tandem Diabetes Care Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.